Hugh Stoddard, MD
Internal Medicine · Sumter, SCNPI 1497743595
Payments from drug & device makers
Across 200 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$980
- Amgen$478
- Novartis$138
- Pfizer$116
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$112
- GSK$111
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 62 | $980 |
| Amgen(2 entities) | 29 | $478 |
| Novartis | 8 | $138 |
| Pfizer | 8 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $112 |
| GSK | 7 | $111 |
| Johnson & Johnson | 7 | $109 |
| E.r. Squibb & Sons, L.L.C. | 7 | $102 |
| Abbott | 5 | $92 |
| Daiichi Sankyo Inc. | 4 | $92 |
| Kowa Pharmaceuticals America, Inc. | 6 | $91 |
| Lilly USA, LLC | 6 | $90 |
| Boehringer Ingelheim | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Amarin Pharma, Inc. | 4 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $65 |
| Dexcom, Inc. | 4 | $64 |
| Eisai Inc. | 2 | $51 |
| Merck | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| AbbVie(2 entities) | 3 | $44 |
| Astellas Pharma US Inc | 2 | $41 |
| Edwards Lifesciences | 2 | $33 |
| Corcept Therapeutics | 1 | $23 |
| Exact Sciences | 1 | $19 |
| Cashflow Solutions, LLC | 2 | $17 |
| Shield Therapeutics Inc | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $13 |
| Vanda Pharmaceuticals Inc. | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$3,270 in reported general payments places this provider in the 80th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 205 | $128,662 |
| MounjaroTirzepatide | 41 | $43,969 |
| JardianceEmpagliflozin | 59 | $40,875 |
| OzempicSemaglutide | 19 | $30,761 |
| JanuviaSitagliptin Phosphate | 26 | $25,821 |
| MyrbetriqMirabegron | 30 | $21,709 |
| JanumetSitagliptin Phos/Metformin Hcl | 19 | $20,340 |
| XareltoRivaroxaban | 15 | $18,374 |
| EntrestoSacubitril/Valsartan | 17 | $14,296 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $12,142 |
| MultaqDronedarone Hcl | 14 | $10,880 |
| FarxigaDapagliflozin Propanediol | 16 | $10,137 |
| Repatha SureclickEvolocumab | 14 | $9,707 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $9,428 |
| Restasis MultidoseCyclosporine | 12 | $7,349 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $116 | $133,868230 claims |
| MerckJanuvia, Janumet | $46 | $46,16145 claims |
| Lilly USA, LLCMounjaro | $90 | $43,96941 claims |
| Boehringer IngelheimJardiance | $76 | $40,87559 claims |
| Novo NordiskOzempic | $980 | $30,76119 claims |
| Astellas Pharma US IncMyrbetriq | $41 | $21,70930 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $13 | $19,56430 claims |
| Johnson & JohnsonXarelto | $109 | $18,37415 claims |
| NovartisEntresto | $138 | $14,29617 claims |
| GSKTrelegy Ellipta | $111 | $12,14213 claims |
| AbbVieRestasis Multidose | $44 | $7,34912 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $4,221323 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,498 internal medicine providers in South Carolina.
Other internal medicine in Sumter
- Rica SantiagoMt Pleasant$10.7M
- Richard MillsMt Pleasant$5.5M
- Yvonne DavisMount Pleasant$2.4M
- David BolsterSummerville$2.3M
- Colby GrossmanSummerville$1.4M
- Amit ShahIndian Land$1.4M
- Philip NicolMurrells Inlet$782K
- Carl SofleyAnderson$673K
- Carl MitchellColumbia$564K
- Jerry BackNorth Charleston$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.